FGF2 and in situ carcinoma: Janot et al. (1995) [26] and Wakulich et al. (2002) [28] have also reported increased FGF-2 staining in well differentiated tumors suggesting that it may be involved in mitosis seen in dysplasia, carcinoma in situ and OSCC.